Facing Myeloma Together – Alberta/Canada

Facing Myeloma Together – Alberta/Canada

Facing Myeloma Together in Alberta

Alberta is a leader in Canadian Multiple Myeloma Research, data generation and cancer therapy.  Continued research and access to new treatments are essential to patients with myeloma who have a hope for a better future.

Facing Multiple Myeloma Together

Multiple Myeloma is a blood cancer that is diagnosed in over 200 Albertans each year.

  • With the availability of new treatments, quality of life and overall survival has been vastly improved as patients are now living with the disease on average for 8-10 years
  • Despite these advances, continuous chemotherapy is necessary for long-term disease control in most patients as ultimately the disease remains incurable.
  • There is an urgent need to ensure patients in Alberta have continued access to ongoing excellence in care and research that allows them to live with multiple myeloma and remain active members of society; continuing to work and enjoy a productive live with their loved ones.

Alberta Research Leadership


Our Volunteer Power

  • The Myeloma Alberta Support Society was established in 2001 and became a registered society in 2008
  • The Southern Alberta Myeloma Patients Support Society was established in 2006 and incorporated in 2009
  • There are almost 500 members in Alberta comprised of patients, caregivers and families
  • Volunteers in Alberta have been extremely proactive in raising funds for myeloma research with over $1.25M raised over the past five years.

Facing Myeloma Together in Canada

Myeloma Canada is the only national non-profit, charitable organization uniquely devoted to the Canadian myeloma patient community.  Founded in 2005 by two myeloma patients, Myeloma Canada is a patient-driven, patient focused, grassroots organization, whose goal is to:

  • Provide educational resources and support patients, families and caregivers
  • Increase awareness of the disease and its effects on the lives of patients and families
  • Promote clinical research and access to new drug trials in Canada
  • Facilitate access to new therapies, treatment options and health care resources

For more details and opportunities offered by Myeloma Canada follow the link Myeloma Canada